Stage II Vulvar Cancer

specific

Stage II includes: T2, N0, M0. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)

Centers

Active Trials

—

Cancer Funding

Top Centers for Stage II Vulvar Cancer(46)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	51.1
2	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	51.1
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	51.1
4	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive	—	—	51.1
5	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	—	—	51.1
6	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive	—	—	51.1
7	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive	—	—	51.1
8	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive	—	—	51.1
9	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	51.1
10	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive	—	—	51.1
11	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	51.1
12	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive	—	—	51.1
13	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	51.1
14	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	51.1
15	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive	—	—	51.1
16	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	51.1
17	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	51.1
18	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	51.1
19	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive	—	—	51.1
20	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive	—	—	51.1
21	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	51.1
22	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	—	51.1
23	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	51.1
24	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	51.1
25	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	51.1
26	Cleveland Clinic Cancer CenterCleveland, OH	—	—	51.1
27	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	51.1
28	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	51.1
29	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	—	51.1
30	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive	—	—	51.1
31	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive	—	—	51.1
32	University of Illinois Cancer CenterChicago, IL	—	—	51.1
33	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	—	51.1
34	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	51.1
35	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive	—	—	51.1
36	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	—	51.1
37	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX	—	—	51.1
38	Cancer Center at IllinoisUrbana, IL	—	—	51.1
39	Stony Brook Cancer CenterStony Brook, NY	—	—	51.1
40	Penn State Cancer InstituteHershey, PA	—	—	51.1
41	The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory	—	—	51.1
42	University of Cincinnati Cancer CenterCincinnati, OH	—	—	51.1
43	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	—	—	51.1
44	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	—	51.1
45	University of Texas Medical Branch Cancer CenterGalveston, TX	—	—	51.1
46	Louisiana Cancer Research CenterNew Orleans, LA	—	—	51.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →